University College is an undergraduate constituent college of Rutgers University established in 1934 to serve adult, part-time and non-traditional students. This division is offered at campuses in the cities of Newark and Camden.

During the past decade, Rutgers University conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutgers University" #1 sponsor was "Rutgers, The State University of New Jersey" with 6 trials, followed by "Humacyte, Inc." with 2 trials sponsored, "Angiodynamics, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored and "BioMérieux" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers University" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 2 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Health Resources and Services Administration (HRSA)" with 1 trials as a collaborator and "Kessler Institute for Rehabilitation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers University" are "Parkinson Disease" (3 trials), "End Stage Renal Disease" (2 trials), "Hemodialysis" (2 trials), "Renal Failure" (2 trials) and "Vascular Access" (2 trials). Many other conditions were trialed in "Rutgers University" in a lesser frequency.

Most popular intervention types in "Rutgers University" are "Device" (6 trials), "Biological" (3 trials), "Diagnostic Test" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Human Acellular Vessel (HAV)" (2 trials), "AMPLEX" (1 trials), "AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE" (1 trials), "Arteriovenous fistula (AVF)" (1 trials) and "Autogenous Bone Graft (ABG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers University" are 16 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rutgers University". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Rutgers University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".